- Expanded offering and stronger international positioning
following external growth operations carried out during the
half-year period
- Solid sales momentum in the "Health, Beauty & Nutrition"
division thanks to new product launches and distribution agreements
initiated in the 1st half of 2023
Regulatory News:
Groupe Berkem (Paris:ALKEM), a leading player in bio-based
chemistry (ISIN code: FR00140069V2 - Ticker: ALKEM), announces
its 2023 First-Half Revenue and provides an update on recent
activity.
Olivier FAHY, Chairman and CEO of Groupe Berkem, stated:
"In an economic context that remains complex, Groupe Berkem's
positioning on four distinct but complementary high-potential
business divisions has once again demonstrated its relevance.
Indeed, we ended the first half of the year with relatively stable
revenue compared with the same period last year, while our two
divisions "Construction & Materials" and "Hygiene &
Protection" were impacted by a building market that has slowed
sharply in recent months, due to inflationary pressures. We are
offsetting this setback thanks to the excellent sales momentum of
our "Health, Beauty & Nutrition" division, boosted by the
ongoing launch of new products and an ever-expanding international
distribution network, which will enable this division to accelerate
in the second half of the year. In addition, our external growth
strategy, embodied by two strategic acquisitions in recent months,
enabled us to extend our offering, notably to the Nutraceuticals
market, and to secure the Group's value chain, while also
initiating the Group's internationalization, which started with our
first foothold in the United States. The in-depth work carried out
by our teams since the beginning of the year, our selective
acquisition policy and the investments we made in our production
facilities, give us confidence in our ability to achieve our
financial targets for 2024."
2023 FIRST-HALF REVENUE
At June 30, 2023, Groupe Berkem revenue stood at €28 million,
relatively stable compared with €28.2 million for the 1st half of
2022.
in € thousands
H1 2023
H1 2022
Change
Construction & Materials
12,459
13,398
-7%
Hygiene & Protection
6,479
6,608
-2%
Health, Beauty & Nutrition
8,556
8,033
+6.5%
Industry
377
104
+262%
Other
86
65
+32%
TOTAL
27,956
28,207
-0.9%
In the 1st half of 2023, revenue for the Construction &
Materials division came to €12.5 million, down 7% on the 1st
half of 2022, heavily impacted by the slowdown in the use of wood
in the construction market. The Hygiene & Protection
division was down slightly by 2%, also impacted by the adverse
conditions in the construction sector, with half-year revenue of
€6.5 million. Revenue in the Health, Beauty & Nutrition
division rose by a healthy +6.5%, underlined by the Group's strong
revenue momentum with the launch of new cosmetics products and the
signing of distribution agreements worldwide. Lastly, the
Industry division continued its growth trajectory, thanks to
new business opportunities secured with the acquisition of Biopress
in early April 2023, and recorded revenue of €0.4m in the first
half of 2023.
2023 FIRST-HALF HIGHLIGHTS
External growth operations
February: Acquisition of
i.Bioceuticals, exclusive North American distributor of
nutritional supplements from the Dutch company INC, enabling Groupe
Berkem to distribute its full range of antioxidant active
ingredients directly in North America, thus broadening its offering
in the Nutraceuticals segment.
April: Acquisition of
Biopress, a French producer of 100% vegetable oils and
proteins. With this operation, the Group now benefits from a local
supply of technical vegetable oils, consolidates its offering for
the "Health, Beauty & Nutrition" and "Industry"
business=divisions, and secures new commercial opportunities in the
food market.
Activity
March: Launch of H2OLIXIR, a new
range of 100% natural floral waters with 97.5% organic content,
aimed at the health and beauty industries.
April: Marketing of Termifuge
K, a ready-to-use preventive anti-termite and water-repellent
solution for the construction industry. This boostedsolution
reduces the content of conventional biocides by 50%, thanks to the
integration of a bio-based booster and the benefits of a
plant-based insecticide, formulated by Groupe Berkem.
International
March: Partnership with
Unipex for the distribution of its cosmetic ingredients in
Benelux and French-speaking Switzerland.
April: Partnership with
Kreglinger for the distribution of its cosmetic ingredients in
the UK.
June: Partnership with
Azelis for the distribution of its cosmetic ingredients in
Thailand and South Korea.
June: Signature of a memorandum
of understanding for the creation of a joint venture between Groupe
Berkem and Groupe Dolidol, the leading pan-African player in
the polyurethane foam, bedding and industrial joinery sectors, to
set up an alkyd resin production and marketing site in Ivory
Coast.
CONFIRMATION OF FINANCIAL TARGETS FOR 2024
The Group confirms its ambition to achieve a revenue of at least
€85 million by 2024 following the external growth operations
carried out. By the same date, the Group's objective is to achieve
an EBITDA margin of around 25%.
ABOUT GROUPE BERKEM
Founded in 1993 by Olivier Fahy, Chairman and Chief Executive
Officer, Groupe Berkem is a leading force in the bio-based
chemicals market. Its mission is to advance the environmental
transition of companies producing the chemicals used in everyday
life (Construction & Materials, Health, Beauty & Nutrition,
Hygiene & Protection, and Industry). By harnessing its
expertise in both plant extraction and innovative formulations,
Groupe Berkem has developed bio-based boosters—unique high-quality
bio-based solutions augmenting the performance of synthetic
molecules. Groupe Berkem achieved revenue of €51.8 million in 2022.
The Group has almost 200 employees working at its head office
(Blanquefort, Gironde) and 4 production facilities in Gardonne
(Dordogne), La Teste-de-Buch (Gironde), Chartres (Eure-et-Loir) and
Tonneins (47).
Groupe Berkem has been listed on Euronext Growth Paris since
December 2021 (ISIN code: FR00140069V2 - ALKEM).
www.groupeberkem.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230731494438/en/
Groupe Berkem Olivier Fahy,
Chairman and CEO Anthony Labrugnas, Chief Financial Officer
Phone: +33 (0)5 64 31 06 60 investisseurs@berkem.com
NewCap Investor Relations
Mathilde Bohin / Nicolas Fossiez
Phone: +33 (0)1 44 71 94 94 berkem@newcap.eu
NewCap Media Relations
Nicolas Merigeau / Antoine Pacquier
Phone: +33 (0)1 44 71 94 94 berkem@newcap.eu
Grafico Azioni Groupe Berkem (EU:ALKEM)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Groupe Berkem (EU:ALKEM)
Storico
Da Mag 2023 a Mag 2024
